Wells Fargo’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $207K | Sell |
58,850
-117,732
| -67% | -$483K | ﹤0.01% | 4686 |
|
|
2025
Q4 | $595K | Buy |
176,582
+75,330
| +74% | +$196K | ﹤0.01% | 4360 |
|
|
2025
Q3 | $133K | Buy |
101,252
+13,756
| +16% | +$14.2K | ﹤0.01% | 5169 |
|
|
2025
Q2 | $62.8K | Buy |
87,496
+3,245
| +4% | +$2.55K | ﹤0.01% | 5429 |
|
|
2025
Q1 | $124K | Buy |
84,251
+1,686
| +2% | +$4.02K | ﹤0.01% | 4988 |
|
|
2024
Q4 | $366K | Buy |
82,565
+17,595
| +27% | +$71.4K | ﹤0.01% | 4394 |
|
|
2024
Q3 | $268K | Buy |
64,970
+1,353
| +2% | +$7.27K | ﹤0.01% | 4386 |
|
|
2024
Q2 | $415K | Buy |
63,617
+12,327
| +24% | +$87.2K | ﹤0.01% | 4028 |
|
|
2024
Q1 | $447K | Buy |
51,290
+6,860
| +15% | +$83.2K | ﹤0.01% | 3967 |
|
|
2023
Q4 | $508K | Sell |
44,430
-150,708
| -77% | -$1.49M | ﹤0.01% | 3857 |
|
|
2023
Q3 | $1.88M | Buy |
195,138
+4,611
| +2% | +$45.2K | ﹤0.01% | 2845 |
|
|
2023
Q2 | $2.03M | Buy |
190,527
+48,077
| +34% | +$517K | ﹤0.01% | 2908 |
|
|
2023
Q1 | $1.5M | Buy |
142,450
+47,551
| +50% | +$533K | ﹤0.01% | 3095 |
|
|
2022
Q4 | $1.18M | Sell |
94,899
-7,438
| -7% | -$84.4K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $1.06M | Sell |
102,337
-141,530
| -58% | -$1.6M | ﹤0.01% | 3202 |
|
|
2022
Q2 | $2.81M | Sell |
243,867
-304,914
| -56% | -$3.59M | ﹤0.01% | 2529 |
|
|
2022
Q1 | $6.9M | Sell |
548,781
-43,419
| -7% | -$498K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $6.91M | Sell |
592,200
-704,839
| -54% | -$8.65M | ﹤0.01% | 2226 |
|
|
2021
Q3 | $16.9M | Buy |
1,297,039
+336,513
| +35% | +$4.35M | ﹤0.01% | 1784 |
|
|
2021
Q2 | $12.4M | Buy |
960,526
+407,825
| +74% | +$4.67M | ﹤0.01% | 2058 |
|
|
2021
Q1 | $6.18M | Buy |
552,701
+147,556
| +36% | +$1.56M | ﹤0.01% | 2640 |
|
|
2020
Q4 | $4.62M | Sell |
405,145
-31,529
| -7% | -$345K | ﹤0.01% | 2832 |
|
|
2020
Q3 | $3.93M | Sell |
436,674
-9,293
| -2% | -$92.4K | ﹤0.01% | 2732 |
|
|
2020
Q2 | $4.6M | Buy |
445,967
+113,364
| +34% | +$1.16M | ﹤0.01% | 2533 |
|
|
2020
Q1 | $3.36M | Sell |
332,603
-4,109
| -1% | -$48.3K | ﹤0.01% | 2566 |
|
|
2019
Q4 | $4.48M | Buy |
336,712
+40,361
| +14% | +$445K | ﹤0.01% | 2664 |
|
|
2019
Q3 | $2.54M | Buy |
296,351
+20,275
| +7% | +$197K | ﹤0.01% | 3130 |
|
|
2019
Q2 | $3.02M | Sell |
276,076
-80,636
| -23% | -$903K | ﹤0.01% | 2987 |
|
|
2019
Q1 | $4.04M | Buy |
356,712
+55,366
| +18% | +$618K | ﹤0.01% | 2754 |
|
|
2018
Q4 | $2.62M | Buy |
301,346
+206,273
| +217% | +$2.37M | ﹤0.01% | 3047 |
|
|
2018
Q3 | $1.47M | Sell |
95,073
-13,606
| -13% | -$215K | ﹤0.01% | 3671 |
|
|
2018
Q2 | $1.74M | Sell |
108,679
-154,136
| -59% | -$2.28M | ﹤0.01% | 3561 |
|
|
2018
Q1 | $3.4M | Buy |
262,815
+16,629
| +7% | +$207K | ﹤0.01% | 2940 |
|
|
2017
Q4 | $3.09M | Buy |
246,186
+48,050
| +24% | +$628K | ﹤0.01% | 3020 |
|
|
2017
Q3 | $2.62M | Buy |
198,136
+73,479
| +59% | +$1.01M | ﹤0.01% | 3094 |
|
|
2017
Q2 | $1.97M | Buy |
124,657
+9,719
| +8% | +$141K | ﹤0.01% | 3233 |
|
|
2017
Q1 | $1.64M | Buy |
114,938
+288
| +0.3% | +$3.94K | ﹤0.01% | 3360 |
|
|
2016
Q4 | $1.47M | Buy |
114,650
+51,981
| +83% | +$657K | ﹤0.01% | 3406 |
|
|
2016
Q3 | $834K | Buy |
62,669
+900
| +1% | +$10.5K | ﹤0.01% | 3602 |
|
|
2016
Q2 | $677K | Sell |
61,769
-2,510
| -4% | -$24.5K | ﹤0.01% | 3730 |
|
|
2016
Q1 | $589K | Buy |
64,279
+6,414
| +11% | +$52.9K | ﹤0.01% | 3769 |
|
|
2015
Q4 | $562K | Buy |
57,865
+10,315
| +22% | +$99.7K | ﹤0.01% | 3853 |
|
|
2015
Q3 | $416K | Sell |
47,550
-124,232
| -72% | -$1.16M | ﹤0.01% | 4055 |
|
|
2015
Q2 | $1.73M | Buy |
171,782
+16,412
| +11% | +$191K | ﹤0.01% | 3189 |
|
|
2015
Q1 | $2.08M | Sell |
155,370
-26,647
| -15% | -$350K | ﹤0.01% | 3007 |
|
|
2014
Q4 | $2.33M | Buy |
182,017
+17,093
| +10% | +$196K | ﹤0.01% | 2899 |
|
|
2014
Q3 | $1.79M | Buy |
164,924
+96,668
| +142% | +$1.11M | ﹤0.01% | 3067 |
|
|
2014
Q2 | $876K | Sell |
68,256
-6,853
| -9% | -$74.5K | ﹤0.01% | 3606 |
|
|
2014
Q1 | $775K | Sell |
75,109
-444,870
| -86% | -$5M | ﹤0.01% | 3644 |
|
|
2013
Q4 | $5.05M | Buy |
519,979
+422,438
| +433% | +$3.79M | ﹤0.01% | 2260 |
|
|
2013
Q3 | $967K | Buy |
97,541
+1,671
| +2% | +$16.4K | ﹤0.01% | 3380 |
|
|
2013
Q2 | $797K | Buy |
+95,870
| New | +$1.16M | ﹤0.01% | 3401 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Wells Fargo's IRWD Position: Q1 2026 in Review
Wells Fargo reduced its Ironwood Pharmaceuticals (IRWD) stake by 67% in Q1 2026, selling an estimated $483K and leaving 58,850 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #4686.
Wells Fargo first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Wells Fargo held 58,850 shares of Ironwood Pharmaceuticals worth $207K as of Q1 2026.
- Wells Fargo sold 117,732 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $483K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4686 holding.
- Wells Fargo first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Ironwood Pharmaceuticals position peaked at $16.9M in Q3 2021.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.